3Chang S, Chen Y, Luh K, et al. In vitro activity of antimicrobial agents, alone and in combination, against Acinetobacter baumanii isolated from blood[J]. Diagn Microbiol Infect Dis,1995, 23(3):105-110. 被引量：1
4Spencer RC. Epidemiology of infections in ICUs[J]. Intensive Care Med, 1994, 20(Suppl 4): S2. 被引量：1
5Widmer AF. Infection control and prevention strategies in the ICU[J]. Intensive Care Med, 1994, 20(Suppl4) : S7. 被引量：1
6Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients[J]. Chest, 1999, 115(2): 462-474. 被引量：1
7Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infection on patient outcomes in the ICU setting[J]. Chest, 2000, 118(1): 146-155. 被引量：1
8Blaster-J, Konig-C, Fatio-R,et al.Multicenter quality control of amikacin assay for monitoring once-daily dosing regimens［J］.International Antimicrobial Therapy Cooprative Group of the European Organization for Research and Treatment of cancer.Ther Drug Monit，1995；Apr;17(2):133 被引量：1
9Blaster-J.Dosing aminoglycosides once a day［J］.Schweiz Med Wochenschr Suppl,1996;76:39S 被引量：1
10Amesterdam D.Susceptibility testing of antimicrobials in liquid media.In lorian V Antibiotitics in laboratory Medicine Fourth ed［M］.New York:Williams &Wilkins，1996:52～111 被引量：1
